Glysantis is pleased to announce the appointment of Dr. Jondavid (Jd) de Jong, as Manager R&D. “Glysantis’ R&D portfolio has been growing...

Glysantis is pleased to announce the promotion of Dr. Karl Klinger to the role of Sr. Scientist. “From his first day here, it was clear t...

Glysantis Inc. is pleased to announce the appointment of Ricky Ghoshal as Director of Strategic Development. Glysantis Inc., is a biotec...

Guelph, May 28, 2018 – Glysantis Inc., a privately held biotechnology company developing novel nanomedicines, announced today that it wil...

Guelph, April 4, 2018 – Glysantis Inc. today announced that it has been selected as a finalist in the RESI at MaRS Toronto Innovation Cha...

Guelph, Jan 3, 2018 – Glysantis Inc. today announced that it will present at Biotech Showcase™ 2018, to be held January 8–10 during the m...

October 5, 2017 - Guelph, ON On Thursday, September 28th Mirexus Biotechnologies Inc., parent organization of Glysantis Inc., hosted a gr...

September 1, 2017 - Guelph, ON Glysantis is pleased to announce that Ricky Ghoshal has joined Glysantis as Sr. Business Development Assoc...

June 21, 2016 - Guelph, ON. Mirexus Biotechnologies Inc. (MBI), a guelph-based nanomaterials company, has created a wholly-owned subsidia...